**Key characteristics:**
* RNY1 is a transmembrane protein with a molecular weight of approximately 130 kDa.
* It is expressed in a variety of cell types in the gastrointestinal tract.
* It is involved in the regulation of epithelial cell function, including cell migration, proliferation, and differentiation.
**Pathways and functions:**
* RNY1 is involved in the regulation of epithelial cell migration. It is expressed in cells that are migrating through the gastrointestinal tract, and it is required for these cells to migrate in the correct direction.
* It is also involved in the regulation of epithelial cell proliferation. It is expressed in cells that are proliferating, and it is required for these cells to maintain their proliferative capacity.
* RNY1 is also involved in the regulation of epithelial cell differentiation. It is expressed in cells that are differentiating into a specific epithelial cell type.
**Clinical significance:**
RNY1 is a promising target for the treatment of gastrointestinal diseases. It is expressed in a variety of cell types that are involved in the development and maintenance of the gastrointestinal tract. Mutations in RNY1 have been linked to a number of gastrointestinal diseases, including celiac disease, Crohn's disease, and ulcerative colitis.
RNY1 is a promising target for the treatment of gastrointestinal diseases because it is a highly conserved protein that is expressed in a variety of cell types. Mutations in RNY1 have been shown to be associated with a number of gastrointestinal diseases, suggesting that it is a key factor in the development of these diseases. Targeting RNY1 with drugs could therefore be a promising way to treat these diseases.
Disclaimer: This summary is generated by an AI language model and may contain inaccuracies or hallucinations. However, it is cross-referenced with curated gene expression data from major biological sources. Please verify the information before use.
